Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Adam Koppel Insider Profile

11 Followers

Adam Koppel, Director, Ten Percent Owner at Kailera Therapeutics, Inc., holds 22.58M shares in Kailera Therapeutics, Inc. (Ticker: KLRA), holds 0.00 shares in Cerevel Therapeutics Holdings (Ticker: CERE), holds 4.03M shares in Solid Biosciences (Ticker: SLDB).

Adam Koppel's Trading History

KLRAKailera Therapeutics, Inc.		Apr 20, 2026Director, Ten Percent OwnerUninformative Buy―$290.42M
CERECerevel Therapeutics Holdings		Aug 05, 2024―Uninformative Sell―$0.00
SLDBSolid Biosciences		Jan 12, 2024Director, Ten Percent OwnerUninformative Buy5.00M$25.01M
BLSABCLS Acquisition		Oct 26, 2020―Uninformative Buy4.88M$4.89M
APTXAptinyx		Jan 16, 2020―Informative Buy10.00M$533.61K
DRNADicerna Pharma		Dec 06, 2019―Informative Sell37.02M$117.85M
BIIBBiogen		Jun 07, 2016EVP, Strategy and Bus. DevUninformative Sell160.95K$749.95K
PTCTPTC Therapeutics		Jun 27, 2013DirectorUninformative Buy―$139.93M
TRVNTrevena		―Director―$0.00
FHTXFoghorn Therapeutics		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Adam Koppel insider profile FAQ

What is the percentage of profitable transactions made by Adam Koppel?
The percentage of profitable transactions made by Adam Koppel is 67%.
What is the average return per transaction made by Adam Koppel?
The average return per transaction made by Adam Koppel is 71.40%.
What stocks does Adam Koppel hold?
Adam Koppel holds: KLRA, BIIB, DRNA, SLDB, APTX, CERE, FHTX, BLSA, PTCT, TRVN stocks.
What was Adam Koppel's most profitable transaction?
Adam Koppel’s most profitable transaction was an Informative Buy of CERE stock on October 29, 2020. The return on the trade was 306.50%.
What is Adam Koppel's role in Kailera Therapeutics, Inc.?
Adam Koppel's role in Kailera Therapeutics, Inc. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.